PLoS ONE (Jan 2012)

Isolation of monoclonal antibodies with predetermined conformational epitope specificity.

  • Anton M Sholukh,
  • Muhammad M Mukhtar,
  • Michael Humbert,
  • Sosthène S Essono,
  • Jennifer D Watkins,
  • Hemant K Vyas,
  • Vivekanandan Shanmuganathan,
  • Girish Hemashettar,
  • Maria Kahn,
  • Shiu-Lok Hu,
  • David C Montefiori,
  • Victoria R Polonis,
  • Peter H Schur,
  • Ruth M Ruprecht

DOI
https://doi.org/10.1371/journal.pone.0038943
Journal volume & issue
Vol. 7, no. 6
p. e38943

Abstract

Read online

Existing technologies allow isolating antigen-specific monoclonal antibodies (mAbs) from B cells. We devised a direct approach to isolate mAbs with predetermined conformational epitope specificity, using epitope mimetics (mimotopes) that reflect the three-dimensional structure of given antigen subdomains. We performed differential biopanning using bacteriophages encoding random peptide libraries and polyclonal antibodies (Abs) that had been affinity-purified with either native or denatured antigen. This strategy yielded conformational mimotopes. We then generated mimotope-fluorescent protein fusions, which were used as baits to isolate single memory B cells from rhesus monkeys (RMs). To amplify RM immunoglobulin variable regions, we developed RM-specific PCR primers and generated chimeric simian-human mAbs with predicted epitope specificity. We established proof-of-concept of our strategy by isolating mAbs targeting the conformational V3 loop crown of HIV Env; the new mAbs cross-neutralized viruses of different clades. The novel technology allows isolating mAbs from RMs or other hosts given experimental immunogens or infectious agents.